Category: Abstracts

  • Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.

    Acta Ophthalmol. 2014 Dec;92(8):713-23. doi: 10.1111/aos.12463. Epub 2014 Jun 12. Broadhead GK 1 , Hong T, Chang AA.

    Read more
  • Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.

    Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1217-25. doi: 10.1007/s00417-014-2799-8. Epub 2014 Sep 10. Zhu M 1 , Chew

    Read more
  • Dietary modification and supplementation for the treatment of age-related macular degeneration.

    Nutr Rev. 2015 Jul;73(7):448-62. doi: 10.1093/nutrit/nuv005. Epub 2015 Apr 28. Broadhead GK 1 , Grigg JR 2 ,

    Read more
  • The role of aflibercept in the management of diabetic macular edema.

    Drug Des Devel Ther. 2015 Aug 6;9:4389-96. doi: 10.2147/DDDT.S62778. eCollection 2015. Chang AA 1 , Hong T 2

    Read more
  • Intravitreal aflibercept for treatment-resistant neovascular age-related maculardegeneration.

    Ophthalmology. 2014 Jan;121(1):188-92. doi: 10.1016/j.ophtha.2013.08.035. Epub 2013 Oct 18. Chang AA 1 , Li H 2 , Broadhead

    Read more
  • Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age- related macular degeneration

    Retina. 2015 May;35(5):975-81. doi: 10.1097/IAE.0000000000000409. Broadhead GK 1 , Hong T, Zhu M, Li H, Schlub TE, Wijeyakumar

    Read more
  • Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes

    Ophthalmic Res. 2015;55(2):84-90. doi: 10.1159/000440886. Epub 2015 Dec 5. Chang AA 1 , Broadhead GK, Hong T, Joachim

    Read more